Skip to main content
Premium Trial:

Request an Annual Quote

Applied DNA Sciences Closes $7.4M Financing Round

NEW YORK, Feb. 15 (GenomeWeb News) - Applied DNA Sciences has raised $7.36 million from a Dec. 30, 2004, stock offering, the Los Angeles-based company said today.

 

The majority of the funds will be used to "vigorously accelerate" marketing, sales, and distribution programs for the company's DNA-based security products, Applied DNA Sciences said in a statement. The company also said that it will use a portion of the funding to establish a US-based laboratory to produce the security products.

 

Applied DNA Sciences has raised a total of just over $10 million in venture capital, according to a company spokesperson. In addition, he said that Taiwanese company Biowell has spent approximately $10 million to create the DNA security technology, to which Applied DNA Sciences is in the process of acquiring all rights, title, and interest.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.